GED Capital taps the preventive medicine sector
Spanish lower mid-market private equity firm GED Capital has acquired a 51 per cent stake in Vitro Group, a manufacturer of equipment, reagents and software platforms for in-vitro diagnostics used in hospital laboratories and research centres.
The remaining shares will remain...